Warren Buffett Pays This Much Into Social Security Each Year
It's probably less than you think.
Vape-Related Health Concerns May Be a Real Problem for These Pot Stocks
More than 450 cases of mysterious lung illnesses, along with five deaths, have been reported across 33 states.
2 Recession-Ready Stocks to Buy Right Now
If a recession hits in 2019 or 2020, these stocks should do better than most.
Keeping up with the news from major medical meetings has become a requirement for healthcare investors.
While third-quarter results included some nice earnings, its overall direction is not encouraging.
Intuitive Surgical and Coca-Cola rose after reporting quarterly earnings.
Find out why these stocks led the market lower.
A recall of its baby powder sparked worries about the healthcare giant's asbestos-related legal battles.
Competition in the faux-meat business is heating up.
Positive earnings helped some stocks escape the market's declines.
The company's current valuation makes it tough to love, but even a modest pullback could bolster the bullish argument
Can this struggling stock get back on track next week?
Headlines raise new questions about the company's handling of the 737 MAX certification process
Here's what investors should be looking for in the e-commerce major's upcoming third-quarter report.
Atlassian's results aren't good enough, and Johnson & Johnson takes a hit to its reputation.
The company gave investors a closer look at its eczema candidate and they liked what they saw.
Is the bag of popcorn half full or half empty?
Its most important business is substantially underperforming expectations.
At least one cannabis company is putting the brakes on its IPO. Will others follow?
The Oracle of Omaha was slammed in a public letter from an advisor, but the missive misses the point.
The small-cap company's shares have fallen 64% in the last year, but a promising drug portfolio might signal an opportunity for investors with a long-term mindset.
Gap's rough year continues after an analyst downgrade and persistent industry pessimism.
The stock still hasn't recovered from a big fall back in August.